1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
Malignant trophoblastic tumours in Norway. Fertility rate after chemotherapy
Article first published online: 19 AUG 2005
DOI: 10.1111/j.1471-0528.1990.tb02551.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 97, Issue 7, pages 623–625, July 1990
Additional Information
How to Cite
KJER, J. J. and IVERSEN, T. (1990), Malignant trophoblastic tumours in Norway. Fertility rate after chemotherapy. BJOG: An International Journal of Obstetrics & Gynaecology, 97: 623–625. doi: 10.1111/j.1471-0528.1990.tb02551.x
Publication History
- Issue published online: 19 AUG 2005
- Article first published online: 19 AUG 2005
- Received 19 August 1989; Accepted 28 January 1990
- Abstract
- References
- Cited By
Summary. During the period 1970–1986, 73 women with malignant trophoblastic tumours were reported in Norway. Forty-six of these women were sent a questionnaire about the course of pregnancies subsequent to treatment with methotrexate and actinomycin D. Only 30 of these women had had the desire to get pregnant; 10 had had one, 13 had had two, and six had had three further children. It is concluded that treatment with combination of methotrexate and actinomycin D is safe in terms of preserving fertility.